Alexandru I. Cuza University, Institute of Interdisciplinary Research, Department of Exact and Natural Sciences, Bulevardul Carol I, Nr.11, Iasi 700506, Romania.
Alexandru I. Cuza University, Institute of Interdisciplinary Research, Department of Exact and Natural Sciences, Bulevardul Carol I, Nr.11, Iasi 700506, Romania.
Microbiol Res. 2024 Sep;286:127822. doi: 10.1016/j.micres.2024.127822. Epub 2024 Jun 26.
Antibiotic resistance represents a global health threat, challenging the efficacy of traditional antimicrobial agents and necessitating innovative approaches to combat infectious diseases. Among these alternatives, antimicrobial peptides have emerged as promising candidates against resistant pathogens. Unlike traditional antibiotics with only one target, these peptides can use different mechanisms to destroy bacteria, with low toxicity to mammalian cells compared to many conventional antibiotics. Antimicrobial peptides (AMPs) have encouraging antibacterial properties and are currently employed in the clinical treatment of pathogen infection, cancer, wound healing, cosmetics, or biotechnology. This review summarizes the mechanisms of antimicrobial peptides against bacteria, discusses the mechanisms of drug resistance, the limitations and challenges of AMPs in peptide drug applications for combating drug-resistant bacterial infections, and strategies to enhance their capabilities.
抗生素耐药性是一个全球性的健康威胁,挑战了传统抗菌药物的疗效,需要创新的方法来对抗传染病。在这些替代品中,抗菌肽作为一种有前途的抗耐药病原体的候选药物已经出现。与只有一个靶标的传统抗生素不同,这些肽可以使用不同的机制来破坏细菌,与许多传统抗生素相比,对哺乳动物细胞的毒性较低。抗菌肽 (AMPs) 具有令人鼓舞的抗菌特性,目前已应用于临床治疗病原体感染、癌症、伤口愈合、化妆品或生物技术。本综述总结了抗菌肽对抗细菌的机制,讨论了耐药机制,以及 AMP 在肽类药物应用中对抗耐药细菌感染的局限性和挑战,并提出了增强其能力的策略。